|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
47,900,000 |
Market
Cap: |
53.65(M) |
Last
Volume: |
92,722 |
Avg
Vol: |
374,904 |
52
Week Range: |
$1.04 - $2.66 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P SMALLCAP 600 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Enzo Biochem is a diagnostics, clinical lab, and life sciences company. Co.'s operating segments include: Enzo Clinical Lab, which is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies; Enzo Life Sciences, which manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide; Enzo Therapeutics, which is a biopharmaceutical venture that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, various of which are derived from the work of Enzo Life Sciences.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
417,900 |
Total Buy Value |
$0 |
$0 |
$0 |
$873,769 |
Total People Bought |
0 |
0 |
0 |
5 |
Total Buy Transactions |
0 |
0 |
0 |
14 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Goldberg David C |
Vice President, Bus. Dev. |
|
2004-08-10 |
4 |
OE |
$7.28 |
$24,375 |
D/D |
3,350 |
73,628 |
|
- |
|
Thalenfeld Barbara E |
VP, Corporate Development |
|
2004-08-10 |
4 |
OE |
$7.28 |
$24,375 |
D/D |
3,350 |
53,117 |
|
- |
|
Lazar Melvin F |
Director |
|
2004-06-17 |
4 |
B |
$13.61 |
$95,284 |
I/I |
7,000 |
50,375 |
2.1 |
- |
|
Warshawsky Stanford S |
01/2004, Resigned as Director |
|
2004-05-04 |
4 |
S |
$14.00 |
$334,605 |
D/D |
(23,500) |
0 |
|
- |
|
Warshawsky Stanford S |
01/2004, Resigned as Director |
|
2004-05-03 |
4 |
S |
$14.60 |
$365,188 |
D/D |
(24,875) |
0 |
|
- |
|
Rabbani Elazar |
Chairman & CEO |
|
2004-04-26 |
4/A |
D |
$16.20 |
$2,093,818 |
D/D |
(129,248) |
1,980,784 |
|
- |
|
Rabbani Elazar |
Chairman & CEO |
|
2004-04-26 |
4/A |
OE |
$7.37 |
$2,093,813 |
D/D |
284,138 |
1,980,784 |
|
- |
|
Rabbani Shahram K |
COO, Treasurer and Secretary |
|
2004-04-26 |
4/A |
D |
$16.20 |
$2,093,818 |
D/D |
(129,248) |
2,000,511 |
|
- |
|
Rabbani Shahram K |
COO, Treasurer and Secretary |
|
2004-04-26 |
4/A |
OE |
$7.37 |
$2,093,813 |
D/D |
284,138 |
2,000,511 |
|
- |
|
Weiner Barry W |
President and CFO |
|
2004-04-26 |
4/A |
D |
$16.20 |
$1,481,279 |
D/D |
(91,437) |
1,194,168 |
|
- |
|
Weiner Barry W |
President and CFO |
|
2004-04-26 |
4/A |
OE |
$7.37 |
$1,481,272 |
D/D |
201,014 |
1,194,168 |
|
- |
|
Rabbani Elazar |
Chairman B of D and CEO |
|
2004-04-26 |
4 |
D |
$7.37 |
$952,429 |
D/D |
(129,248) |
1,984,118 |
|
- |
|
Rabbani Elazar |
Chairman B of D and CEO |
|
2004-04-26 |
4 |
OE |
$7.37 |
$2,093,813 |
D/D |
284,138 |
1,984,118 |
|
- |
|
Weiner Barry W |
President and Director |
|
2004-04-26 |
4 |
D |
$7.37 |
$673,799 |
D/D |
(91,437) |
1,200,108 |
|
- |
|
Weiner Barry W |
President and Director |
|
2004-04-26 |
4 |
OE |
$7.37 |
$1,481,272 |
D/D |
201,014 |
1,200,108 |
|
- |
|
Rabbani Shahram K |
COO, Treasurer and Secretary |
|
2004-04-26 |
4 |
D |
$7.37 |
$952,429 |
D/D |
(129,248) |
2,006,410 |
|
- |
|
Rabbani Shahram K |
COO, Treasurer and Secretary |
|
2004-04-26 |
4 |
OE |
$7.37 |
$2,093,813 |
D/D |
284,138 |
2,006,410 |
|
- |
|
Rabbani Elazar |
Chairman BOD&CEO |
|
2004-04-20 |
4 |
S |
$16.11 |
$54,427 |
D/D |
(3,335) |
2,110,375 |
|
- |
|
Weiner Barry W |
President |
|
2004-04-20 |
4 |
S |
$16.11 |
$54,411 |
D/D |
(3,334) |
1,288,547 |
|
- |
|
Rabbani Shahram K |
COO, Treasurer and Secretary |
|
2004-04-20 |
4 |
S |
$16.11 |
$54,394 |
D/D |
(3,333) |
2,132,702 |
|
- |
|
Thalenfeld Barbara E |
VP, Corporate Development |
|
2004-04-19 |
4 |
B |
$7.37 |
$24,686 |
D/D |
3,350 |
56,467 |
2.74 |
- |
|
Lazar Melvin F |
Director |
|
2004-03-22 |
4 |
B |
$15.80 |
$80,975 |
I/I |
5,125 |
41,250 |
2.1 |
- |
|
Lazar Melvin F |
Director |
|
2004-03-22 |
4/A |
B |
$15.80 |
$80,975 |
I/I |
5,125 |
43,375 |
2.1 |
- |
|
Engelhardt Dean |
Executive Vice President |
|
2004-02-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,401 |
172,299 |
|
- |
|
Engelhardt Dean |
Executive Vice President |
|
2004-01-26 |
4 |
S |
$19.80 |
$383,133 |
D/D |
(19,176) |
158,898 |
|
- |
|
264 Records found
|
|
Page 10 of 11 |
|
|